Drug photosensitivity, idiopathic photodermatoses, and sunscreens

Journal of the American Academy of Dermatology

Volumn 35, Issue 6, 1996, Pages 871-885

  González, Ernesto ^a   González, Salvador ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; 4 AMINOBENZOIC ACID DERIVATIVE; 4 ISOPROPYLDIBENZOYLMETHANE; 6 METHYLCOUMARIN; AMIODARONE; ANTHRANILIC ACID METHYL ESTER; AVOBENZONE; AZAPROPAZONE; BENOXAPROFEN; CARPROFEN; CHLORPROMAZINE; CIPROFLOXACIN; COPPERTONE; CORTICOSTEROID; DEMECLOCYCLINE; ENOXACIN; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HOMOSALATE; LOMEFLOXACIN; MAXAFIL; METHOXSALEN; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; OXYBENZONE; PABANOL; PEFLOXACIN; PHENOTHIAZINE DERIVATIVE; PHOTOPLEX; PHOTOSENSITIZING AGENT; PIROXICAM; PRESUN 15; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SOLBAR; SUNBRELLA; SUNDOWN; SUNSCREEN; SUPRASHADE; TIAPROFENIC ACID; ULTRASHADE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CLINICAL FEATURE; DIAGNOSIS; DRUG THERAPY; ETIOLOGY; HUMAN; ORAL DRUG ADMINISTRATION; PHOTOALLERGY; PHOTODERMATOSIS; PHOTOSENSITIZATION; PREVENTION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SKIN ALLERGY; SKIN PROTECTION; SOLAR URTICARIA; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

EID: 0029731548     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90108-5     Document Type: Article

References (139)

1. Spikes JD. Photosensitization. In: Smith KC, editor. The science of photobiology. New York: Plenum, 1977:87-110.
2. Ayd JF Jr. The dermatologic and systemic manifestations of chlorpromazine hypersensitivity: their clinical significance and management. J Nerv Mental Dis 1956;124: 84-7.
3. Calnan CD, Frain Bell W, Cuthbert JW. Occupational dermatitis from chlorpromazine. Trans St John's Hosp Derm Soc 1962;48:49-74.
4. Orentreich A, Harber LC, Tromovitch TA. Photosensitivity and photoonycholysis due to demethylchlortetracycline. Arch Dermatol 1961;83:730-7.
5. Halkin H. Adverse effects of the fluoroquinolones. Rev Infect Dis 1988;10(suppl):S258-61.
6. Parrish JA, Jaenicke KF, Anderson RR. Erythema and melanogenesis action spectra of normal human skin. Photochem Photobiol 1982;36:187-91.
7. Fredrich JE, Snell HE, Haywood EK. Solar ultraviolet radiation at the earth's surface. Photochem Photobiol 1989;50:443-50.
8. Johnson BE, Ferguson J. Drug and chemical photosensitivity. In: Maibach HI, editor. Seminars in dermatology. Philadelphia, WB Saunders, 1990:39-46.
9. Harber LC. Abnormal responses to ultraviolet radiation: drug-induced photosensitivity. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, editors. Dermatology in general medicine. New York: McGraw-Hill, 1993:1677-89.
10. Ledo E. Photodermatosis. Part 1: Photobiology, photoimmunology, and idiopathic photodermatoses. Int J Dermatol 1993;12:387-96.
11. Peak MJ, Peak JG, Churchill ME. Cellular and molecular effects of UVA radiation and visible light in mammalian cells. In: Urbach F, editor. Biological response to ultraviolet A radiation. Overland Park, KS: Valdenmer Publishing, 1992:39-46.
12. Goldstein BD, Harber LC. Erythropoietic porphyria: lipid peroxidation and red cell membrane damage associated with photochemolysis. J Invest Dermatol 1972;51:892-902.
13. Kollias N, Baqer AH. The role of human melanin in providing photoprotection from solar mid-ultraviolet radiation (280-320 nm). J Soc Cosmet Chem 1988;39:347-54.
14. Berger TG, Dhar A. Lichenoid photoeruptions in human immunodeficiency virus infection. Arch Dermatol 1994; 130:609-13.
15. Pappert A, Grossman M, DeLeo V. Photosensitivity as the presenting illness in four patients with human immunodeficiency viral infection. Arch Dermatol 1994;130:618-23.
16. Spikes JD. Photodynamic reactions in photomedicine. In: Regan J, Parrish JA, editors. The science of photomedicine. New York: Plenum Press, 1982:113-44.
17. Bissett DL, Chatterjee R, Hannon DP. Photoprotective effect of superoxide scavenging antioxidants against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Photodermatol Photoimmunol Photomed 1990;7:56-62.
18. Parrish JA, Fitzpatrick TB, Shea C, et al. Photochemotherapy of vitiligo: use of orally administered psoralens and a high-intensity long-wave ultraviolet light system. Arch Dermatol 1976;112:1531-4.
19. Gonzalez E. PUVA for psoriasis. Dermatol Clin 1995; 13:851-66.
20. Gonzalez E, Momtaz T K, Freedman S. Bilateral comparison of generalized lichen planus treated with psoralens and ultraviolet A. J Am Acad Dermatol 1984;10: 958-61.
21. Lim HW, Novotny H, Gigli I. Role of complement and polymorphonuclear cells in demethylchlortetracycline-induced phototoxicity in guinea pigs. J Clin Invest 1983; 71:1326-35.
22. Lam SK, Tomlinson DR. Chlorpromazine-induced histamine release from guinea pig skin in vitro: a photosensitivity reaction. Arch Dermatol Res 1976;255:219-23.
23. Falk MS. Light sensitivity to demethylchlortetracycline: report of four cases. JAMA 1960;172:156-8.
24. Bjellerup M, Ljunggren B. Double blind cross-over studies on phototoxicity to three tetracycline derivatives in human volunteers. Photodermatology 1987;4:281-7.
25. Bjellerup M. Tetracycline phototoxicity: an experimental and clinical study. PhD thesis. Lund, Sweden, 1986.
26. Kochevar IE. Mechanisms of drug photosensitization. Photochem Photobiol 1987;45:891-5.
27. Piette J, Decuyper J, Van De Vorst A. DNA alterations photosensitized by tetracycline and some of its derivatives. J Invest Dermatol 1986;86:653-8.
28. Chalmers RJ, Muston HL, Srinivas V, et al. High incidence of amiodarone-induced photosensitivity in Northwest England. Br Med J 1982;285:341-2.
29. Hasan T, Kochevar IE, Abdulah D. Amiodarone phototoxicity to human erythrocytes and lymphocytes. Photochem Photobiol 1984;40:715-9.
30. Ljunggren B, Bjellerup M, Moller H. Experimental studies on the mechanism of benoxaprofen photoreactions. Arch Dermatol Res 1983;275:318-23.
31. Ljunggren B, Bjellerup M. Systemic drug photosensitivity. Photodermatology 1986;3:26-35.
32. Kochevar IE, Hoover KW, Gawienowski M. Benoxaprofen photosensitization of cell membrane disruption. J Invest Dermatol 1984;82:214-8.
33. Kochevar IE, Morison WL, Lamm JL, et al. Possible mechanisms of piroxicam-induced photosensitivity. Arch Dermatol 1986;12:1283-7.
34. Stern R. Phototoxic reactions to piroxicam and other nonsteroidal anti-inflammatory agents. N Engl J Med 1983;309:186-7.
35. Ikezawa Z, Kitamura K, Osawa J, et al. Photosensitivity to piroxicam is induced by sensitization to thimerosal and thiosalicylate. J Invest Dermatol 1992;98:918-22.
36. Epstein S. Chlorpromazine photosensitivity: phototoxic and photoallergic reactions. Arch Dermatol 1968;98: 354-63.
37. Ljunggren B, Möller H. Phenothiazine phototoxicity: an experimental study in chlorpromazine and its metabolites. J Invest Dermatol 1977;68:313-7.
38. Ljunggren B. Phenothiazine phototoxicity: toxic chlorpromazine photoproducts. J Invest Dermatol 1977;69: 383-6.
39. Hunter JAA, Bhutani LK, Magnus IA. Chlorpromazine photosensitivity in the mouse: its action spectrum and the effect of anti-inflammatory agents. Br J Dermatol 1970; 82:157-68.
40. Takayama S, Hirohashi M, Kato M, et al. Toxicity of quinolone antimicrobial agents. J Toxicol Environ Health 1995;45:1-45.
41. Baes H. Photosensitivity caused by nalidixic acid. Dermatologica 1968;136:61-4.
42. Lesher GY, Froelich EJ, Gruett MD, et al. 1,8-Naphtyridine derivatives: a new class of chemotherapeutic agents. J Med Pharm Chem 1962;5:1063-8.
43. Birkett DA, Garrets M, Stevenson CJ. Phototoxic bullous eruptions due to nalidixic acid. Br J Dermatol 1969; 81:342-4.
44. Ramsay CA, Obreshkova E. Photosensitivity from nalidixic acid. Br J Dermatol 1974;91:523-8.
45. Brauner GJ. Bullous photoreaction to nalidixic acid. Am J Med 1975;58:576-80.
46. Baran R, Brun P. Photoonycholysis induced by fluoroquinolones perfloxacine and ofloxacine. Dermatologica 1986;173:185-8.
47. Izu R, Gardeazabal J, González M, et al. Enoxacin-induced photosensitivity: study of two cases. Photodermatol Photoimmunol Photomed 1992;9:86-8.
48. Kurumaji Y, Shono M. Scarified photopatch testing in lomefloxacin photosensitivity. Contact Dermatitis 1992; 26:5-10.
49. Nedorost ST, Dijkstra JWE. Drug-induced photosensitivity reaction. Arch Dermatol 1989;125:433-4.
50. Granowitz EV. Photosensitivity rash in a patient being treated with ciprofioxacin. J Infect Dis 1989;160:910-1.
51. Fujita H, Matsuo I. In vitro phototoxic activities of new quinolone antibacterial agents: lipid peroxidative potentials. Photodermatol Photoimmunol Photomed 1994;10: 202-5.
52. Christ W, Lehnert T. Toxicity of the quinolones. In: Siporin C, Heifetz CL, Domagala JM, editors. The new generation of quinolones. New York: Marcel Dekker. 1990:165-86.
53. Wagai N, Tawara K. Possible direct role of reactive oxygens in the cause of cutaneous phototoxicity induced by five quinolones in mice. Arch Toxicol 1992;66:392-7.
54. Wagai N, Tawara K. Possible reasons for difference in phototoxicity of 5 quinolone antibacterial agents: generation of toxic oxygen. Free Radic Res Comm 1992;17: 387-98.
55. Dayhaw-Barker P, Truscott TG. Direct detection of singlet oxygen sensitized by nalidixic acid: the effect of pH and melanin. Photochem Photobiol 1988;47:765-7.
56. Ljunggren B. Severe phototoxic burn following celery ingestion. Arch Dermatol 1990;126:1134-6.
57. Crow KD, Alexander E, Buck WHL, et al. Photosensitivity due to pitch. Br J Dermatol 1961;73:220-2.
58. Epstein JH, Tuffanelli DL, Seibert JS, et al. Porphyria-like cutaneous changes induced by tetracycline hydrochloride photosensitization. Arch Dermatol 1976;112:661-6.
59. Johnson BE, Walker EM, Hetherington AM. In vitro models for cutaneous phototoxicity. In: Marks R, Plewig G, editors. Skin models to study function and disease of skin. New York: Springer-Verlag, 1986:264-81.
60. Ison AE, Davis CM. Phototoxicity of quinoline methanols and other drugs in mice and yeast. J Invest Dermatol 1969;52:193-8.
61. Ljunggren B. The mouse tail phototoxicity test. Photodermatology 1984;1:96-100.
62. Hori T. Chlorpromazine photoallergy: coexistence of immediate and delayed type. Arch Dermatol 1975;111: 1469-71.
63. Harber LC, Harris H, Baer RL. Photoallergic contact dermatitis due to halogenated salicylanilides and related compounds. Arch Dermatol 1966;94:255-62.
64. Harber LC, Targovnik SE, Baer RL. Contact photosensitivity patterns to halogenated salicylanilides, in man and guinea pigs. Arch Dermatol 1967;96:646-56.
65. Kato S, Seki T, Katsumura Y, et al. Mechanism for 6-methylcoumarin photoallergenicity. Toxicol Appl Pharmacol 1985;18:295-301.
66. Smith SZ, Epstein JH. Photocontact dermatitis to halogenated salicylanilides and related compounds. Arch Dermatol 1977;113:1372-4.
67. Raugi GJ, Storrs J, Larsen WG. Photoallergic contact dermatitis to men's perfumes. Contact Dermatitis 1979;5: 251-60.
68. Wojnarowska F, Calnan CD. Contact and photocontact allergy to musk ambrette. Br J Dermatol 1986;114: 667-75.
69. Maguire HC, Kaidbey K. Studies in experimental photoallergy. In: Parrish JA, editor. The effect of ultraviolet radiation on the immune system. Skillman, NJ: Johnson & Johnson, 1983:181-92.
70. Granstein RD, González E. Photoallergic contact dermatitis. In: Provost TT, Farmer ER, editor. Current therapy in dermatology: 2. Toronto: BC Decker, 1988:168-71.
71. Bilsland D, Diffey BL, Farr PM, et al. Diagnostic phototesting in the United Kingdom. Br J Dermatol 1992;127: 297-9.
72. Frain-Bell WC. Drug-induced photosensitivity. In: Frain-Bell WC, editor. Cutaneous photobiology. Oxford: Oxford University Press 1985:125-52.
73. Harber LC, Lashinsky AM, Baer RL. Skin manifestations of photosensitivity due to chlorothiazide and hydrochlorothiazide. J Invest Dermatol 1959;33:83-4.
74. Wolf R, Dorfman B, Krakowski A. Quinidine-induced lichenoid and eczematous photodermatitis. Dermatologica 1987;174:285-9.
75. Tan SV, Barth-Jones J, Burns DA. Lichen planus and photo-onycholysis induced by quinine [letter]. Clin Exp Dermatol 1989;21:1304-5.
76. Wilkinson DS. Photodermatitis due to tetrachlorosalicylanilide. Br J Dermatol 1961;73:213-9.
77. Jillson OF, Baughman RD. Contact photodermatitis from bithionol. Arch Dermatol 1963;88:409-18.
78. Kaidbey KH, Messenger JL. The clinical spectrum of the persistent light reactor. Arch Dermatol 1984;120:1441-8.
79. Morison WL. Other photodermatoses. In: Parrish JA, Kripke MI, Morison WL, editors. Photoimmunology. New York: Plenum Press, 1983:267-71.
80. Lim HW, Morison WL, Kamide R, et al. Chronic actinic dermatitis: an analysis of 51 patients evaluated in the United States and Japan. Arch Dermatol 1994;130:1284-9.
81. Morison WL, Stern RS. Polymorphous light eruption: a common reaction uncommonly recognized. Acta Derm Venereol (Stockh) 1982;62:237-40.
82. Epstein JH. Polymorphous light eruption. J Am Acad Dermatol 1980;3:329-43.
83. Van Praag MCG, Boom BW, Vermeer JB. Diagnosis and treatment of polymorphous light eruption. Int J Dermatol 1994;33:233-9.
84. Jansen CT. Heredity of chronic polymorphous light eruptions. Arch Dermatol 1978;114:188-90.
85. Holzle E, Plewig G, von Kries R, et al. Polymorphous light eruption. J Invest Dermatol 1987;88(suppl):32s-8s.
86. Harber LC, Bickers DR. Polymorphous light eruption. In: Photosensitivity diseases: principles of diagnosis and treatment. 2nd ed. Toronto: BC Decker, 1989:219-34.
87. Hawk J, Cheong WK. Eczematous photodermatoses. In: Marks R, editor. Eczema. London: Martin Dunitz, 1992: 149-56.
88. Ortel B, Tanew A, Wolff K, et al. Polymorphous light eruption: action spectrum and photoprotection. J Am Acad Dermatol 1986;14:748-53.
89. Epstein JH. Polymorphous light eruption. Dermatol Clin 1986;4:243-51.
90. Sckenius A, Fischer T, Forsum U. Phenotypic characterization in situ of inflammatory cells in allergic and irritant contact dermatitis in men. Clin Exp Immunol 1984;55: 81-90.
91. Jansen CT, Karvonen J. Polymorphous light eruption: a seven-year follow-up evaluation of 114 patients. Arch Dermatol 1984;120:862-5.
92. Magnus IA. Hydroa vacciniforme. In: Dermatological photobiology. Oxford: Blackwell 1976:189-90.
93. Addo HA, Frain-Bell W. Actinic prurigo: A specific dermatosis? Photodermatology 1984;1:119-28.
94. Birt AR, Davis RA. Hereditary polymorphous light eruption of American Indians. Int J Dermatol 1975;14: 105-11.
95. Murphy GM, Hawk JLM, Magnus IA. Hydroxychloroquine in polymorphous light eruption: a controlled trial with drug and visual sensitivity monitoring. Br J Dermatol 1987;116:379-86.
96. Parrish JA, Levine MJ, Morison WL, et al. Comparison of PUVA and beta-carotene in the treatment of polymorphous light eruption. Br J Dermatol 1979;110:193-7.
97. Murphy GM, Logan RA, Lowell CR. Prophylactic PUVA and UVB therapy in polymorphous light eruption: a controlled trial. Br J Dermatol 1986;116:531-8.
98. Saul A, Flores O, Novales J. Polymorphous light eruption: treatment with thalidomide. Australas J Dermatol 1976; 17:17-21.
99. Norris PG, Hawk JLM. Successful treatment of severe polymorphous light eruption with azathioprine. Arch Dermatol 1989;125:1377-9.
100. Lawrence N, Ray MC, Gattely LE III. Photoimmunology: solar urticaria. In: Ray MC, editor. Applied immunodermatology. New York: Igaku-Shoin, 1992:72-4.
101. Monfrecola G, Nappa P, Pini D. Solar urticaria in the visible spectrum successfully treated with astemizole. Dermatologica 1990;180:154-6.
102. Morison WL. Solar urticaria. In: Parrish JA, Kripke MI, Morison WL, editor. Photoimmunology. New York: Plenum Press, 1983:215-26.
103. Ramsay CA. Solar urticaria treatment by inducing tolerance to artificial radiation and natural light. Arch Dermatol 1977;113:1222-5.
104. Ramsay CA, Black A. Photosensitive eczema. Trans St Johns' Hosp Dermatol Soc 1973;59:152-8.
105. Ive FA, Magnus IA, Warin RP. Actinic reticuloid: a chronic photodermatosis associated with severe photosensitivity and histological resemblance to lymphoma. Br J Dermatol 1969;81:469-85.
106. Kingston TP, Lowe NJ, Sofen HL, et al. Actinic reticuloid in a black man: successful therapy with azathioprine. J Am Acad Dermatol 1987;16:1079-83.
107. Toonstra J, Henquet CJM, van Weelden H. Actinic reticuloid. J Am Acad Dermatol 1989;21:205-14.
108. Leigh IM, Hawk JLM. Treatment of chronic actinic dermatitis with azathioprine. Br J Dermatol 1984;110: 691-5.
109. Bilsland D, Crombie IK, Ferguson J. The photosensitivity dermatitis and actinic reticuloid syndrome: no association with lymphoreticular malignancy. Br J Dermatol 1994;131:209-14.
110. Heller P, Wieczorek R, Waldo E, et al. Chronic actinic dermatitis, an immunohistochemical study of its T-cell antigenic profile, with comparison to cutaneous T-cell lymphoma. Am J Derm Pathol 1994;16:510-6.
111. Frain-Bell W, Hetherington A, Johnson BE. Contact allergic sensitivity to chrysanthemum and the photosensitivity dermatitis and actinic reticuloid syndrome. Br J Dermatol 1979;101:491-501.
112. Norris PG, Hawk JLM. Chronic actinic dermatitis. Arch Dermatol 1990;126:376-8.
113. Hindson C, Spiro J, Downey A. PUVA therapy of chronic actinic dermatitis. Br J Dermatol 1985;113:157-60.
114. Morison WL, White HAD, González E, et al. Oral methoxalen photochemotherapy of uncommon photodermatoses. Acta DermVenereol (Stockh) 1979;59: 366-8.
115. Humbert P, Drobacheff C, Vigan M. Chronic actinic dermatitis responding to danazol. Br J Dermatol 1991;124: 195-7.
116. Biren CA, Barr RJ Dermatologic applications of cyclosporine A. Arch Dermatol 1986;122:1028-32.
117. Norris PG, Camp RDR, Hawk JLM. Actinic reticuloid: response to cyclosporine A. J Am Acad Dermatol 1989; 21:307-9.
118. Sayre RM, Kollias N, Roberts RL, et al. Physical sunscreens. J Soc Cosmet Chem 1990;41:109-9.
119. Gilchrest BA, Soter NA, Hawk JL M, et al. Histologic changes associated with ultraviolet A-induced erythema in normal human skin. J Am Acad Dermatol 1983;3:213-9.
120. 1α, and histamine in human skin following UVA irradiation. J Invest Dermatol 1983;80: 496-9.
121. Matsui MS, DeLeo VA. Induction of protein kinase C activity by ultraviolet radiation. Carcinogenesis 1990;11: 229-34.
122. Chew S, DeLeo VA, Harber LC. Long-wave ultraviolet radiation (UVA)-induced alteration of epidermal DNA synthesis. Photochem Photobiol 1988;47:383-9.
123. Paul BS, Parrish JA. The interaction of UVA and UVB in the production of threshold erythema. J Invest Dermatol 1982;78:371-4.
124. Urbach F. Ultraviolet A transmission by modern sunscreens: Is there a real risk? Photodermatol Photoimmunol Photomed 1992/1993;9:237-41.
125. Lowe NJ. Photoprotection. Semin Dermatol 1990;9: 78-83.
126. Menter JM. Recent developments in UVA photoprotection. Int J Dermatol 1990;29:389-401.
127. Ramsay CA: Ultraviolet A protective sunscreens. Clin Dermatol 1989;7:163-166.
128. Pathak MA, Fitzpatrick TB. Preventive treatment of sunburn, dermatoheliosis, and skin cancer with sun-protective agents. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, editor. Dermatology and general medicine. New York: McGraw-Hill, 1993:1689-717.
129. Klein K. Encyclopedia of UV absorbers for sunscreen products. Cosmet Toiletries 1992;107:45-62.
130. Stiller MJ, Davis IC, Shupack JL. A concise guide to topical sunscreens: state of the art. Int J Dermatol 1992;31: 540-3.
131. Dromgoole SH, Maibach HI. Contact sensitization and photocontact sensitization of sunscreening agents. In: Lowe NJ, Shaath NA, editors. Sunscreens: development, evaluation, and regulatory aspects. Cosmetic Science and Technology Series; vol 10. New York: Marcel Dekker, 1990:313-40.
132. Foley F, Nickson R, Marks R, et al. The frequency of reactions to sunscreens: results of a longitudinal population-based study on the regular use of sunscreens in Australia. Br J Dermatol 1993;128:512-8.
133. Pathak MA. Sunscreens: topical and systemic protection against solar radiation for human skin. Photochem Photophys 1987;4(suppl):447-61.
134. Collins P, Ferguson J. Photoallergic contact dermatitis to oxybenzone. Br J Dermatol 1994;131:124-9.
135. Szczurko C, Dompmartin A, Michel M, et al. Photocontact allergy to oxybenzone: ten years of experience. Photodermatol Photoimmunol Photomed 1994;10:144-7.
136. DeLeo VA, Suarez SM, Maso MJ. Photoallergic contact dermatitis: results of photopatch testing in New York, 1985 to 1990. Arch Dermatol 1992;128:1513-8.
137. Rietschel RL, Lewis CW. Contact dermatitis to homomenthyl salicylate. Arch Dermatol 1978;114:442-3.
138. De Groot AC, Weyland JW. Contact allergy to butyl methoxydibenzoylmethane. Contact Dermatitis 1987; 16:278.
139. Motley RJ, Reynolds AJ. Photocontact dermatitis due to isopropyl and butyl methoxy dibenzoylmethanes (Eusolex 8020 and Parsol 1789). Contact Dermatitis 1989; 21:109-10.